Multiple Physical Symptoms After Repeated Negative Tests

An adult reports eighteen months of migrating pain, fatigue, dizziness, abdominal discomfort, and intermittent tingling. Emergency and outpatient evaluations have included repeated blood panels, CT scans, cardiac testing, and several referrals without a unifying structural diagnosis. Symptoms are disabling and real, sleep is poor, work attendance has fallen, and health related worry occupies hours each day. The task is not to declare that nothing is wrong, but to identify current threats, understand prior evidence, and build care around function and reversible contributors.

Case focus#

The central decision is how to stop low yield repetitive testing while preserving a reliable route for evaluating genuinely new or progressive findings. A psychiatric formulation should not be based solely on normal tests, and additional investigations should be tied to a specific hypothesis, discriminating result, and action rather than used as temporary reassurance.

This analysis concentrates on what happens after the first decision. It treats handoffs, result ownership, medication reconciliation, functional recovery, and scheduled reassessment as part of the clinical intervention.

Problem representation#

The useful representation is not a label alone. It combines the tempo of the problem, the setting, the physiologic or functional threat, the evidence already available, and the important information that is still missing. For this persistent physical symptoms analysis, the working frame must remain broad enough to compare Persistent physical symptom disorder, Anxiety, panic, or depressive illness, Medication or substance effect, Sleep disorder and deconditioning without allowing a familiar first impression to become an untested conclusion.

The setting materially changes the plan: A longitudinal primary care clinic with access to prior results, scheduled follow-up, behavioral health, rehabilitation, and targeted referral when findings change.. Available monitoring, access to consultation, travel time, record continuity, and the reliability of follow-through alter what counts as a safe next step. A plan that is reasonable in a continuously monitored environment may be unsafe when results return after discharge or urgent reassessment is difficult.

Immediate safety priorities#

• Objective neurologic change: New focal weakness, pathologic reflexes, persistent sensory level, gait decline, seizure, or sphincter dysfunction requires renewed localization and urgent evaluation.
• Systemic inflammatory or malignant pattern: Documented fever, progressive weight loss, night sweats, lymphadenopathy, organ enlargement, or persistently abnormal inflammatory evidence changes the prior probability.
• Bleeding or organ dysfunction: Melena, hematochezia, hematuria, anemia, jaundice, reduced urine output, hypoxemia, or hemodynamic change cannot be attributed to a prior functional formulation.
• Mental health crisis: Suicidal thinking, inability to care for basic needs, substance withdrawal, or severe panic with unsafe behavior needs immediate direct assessment.

These findings are action signals rather than diagnostic shortcuts. They determine the pace of stabilization, consultation, and escalation while the causal analysis continues in parallel.

Prioritized differential diagnosis#

Persistent physical symptom disorder#

What supports it. Multiple distressing symptoms, disproportionate health preoccupation, repeated care seeking, and major functional impairment may fit a positive biopsychosocial formulation.

What argues against it or keeps uncertainty open. Normal tests alone do not establish this diagnosis, and objective progression or an incomplete prior evaluation must be addressed.

Discriminating next step. Assess symptom related thoughts and behaviors, function, duration, and comorbid conditions while maintaining an explicit pathway for new findings.

Anxiety, panic, or depressive illness#

What supports it. Episodic autonomic symptoms, persistent worry, sleep disruption, low mood, anhedonia, and avoidance can amplify and be amplified by physical symptoms.

What argues against it or keeps uncertainty open. Psychiatric symptoms do not exclude coexisting medical disease and should not explain focal objective abnormalities.

Discriminating next step. Use a direct mental health interview and validated measures, assess safety, and offer evidence based psychological or pharmacologic treatment as appropriate.

Medication or substance effect#

What supports it. Sedatives, anticholinergics, stimulants, supplements, alcohol, cannabis, withdrawal, or duplicate medicines can produce dizziness, fatigue, pain, and gastrointestinal symptoms.

What argues against it or keeps uncertainty open. Symptoms that clearly predate exposure and persist through a verified discontinuation are less likely to be caused primarily by it.

Discriminating next step. Reconcile all products, map dose timing to symptoms, and use a monitored deprescribing or substitution trial when safe.

Sleep disorder and deconditioning#

What supports it. Nonrestorative sleep, snoring, irregular schedule, low activity, orthostatic intolerance, and loss of strength can sustain broad symptom burden.

What argues against it or keeps uncertainty open. They do not explain a new focal deficit, inflammatory pattern, or organ injury.

Discriminating next step. Assess sleep apnea risk, sleep schedule, orthostatic vitals, activity tolerance, and response to a paced rehabilitation plan.

Unrecognized medical disease#

What supports it. A coherent new pattern, objective examination change, strong family history, exposure, or previously unperformed discriminating test can reveal a missed condition.

What argues against it or keeps uncertainty open. Stable symptoms with repeated high quality targeted negative evaluations and no objective trajectory lowers probability of many structural diseases.

Discriminating next step. Test only a named hypothesis whose result would change management, and compare it with prior studies before repeating anything.

The differential is ranked but not closed. Probability, consequence of delay, reversibility, and test burden are considered together. A dangerous alternative can deserve early exclusion even when it is not the statistically most likely explanation.

Evidence-gathering strategy#

• Create a longitudinal evidence map. Symptoms, functional changes, medicines, examinations, tests, consultations, and responses must be aligned in time to see what remains unanswered. Interpretation: True data gaps justify targeted work; duplicated normal testing supports a different management strategy.
• Repeat a complete threat focused examination. A prior formulation should never replace current vital signs, neurologic assessment, organ review, and targeted physical examination. Interpretation: Any objective change reopens the differential; stable findings support planned continuity rather than emergency repetition.
• Assess function and symptom impact. Sleep, mobility, work, caregiving, nutrition, social participation, and avoidance define severity and measurable treatment goals. Interpretation: Functional improvement can demonstrate benefit even before every symptom resolves.
• Review mental health and trauma safely. Anxiety, depression, panic, trauma, substance use, and safety can alter symptoms and deserve direct treatment without invalidating physical experience. Interpretation: A positive finding adds a treatable dimension; it does not cancel medical monitoring.
• Predefine testing thresholds. Linking specific new signs to specific tests prevents both indiscriminate panels and neglect of a changed syndrome. Interpretation: No threshold means no test today; crossing a threshold triggers the agreed focused pathway rather than debate about whether symptoms are real.

Tests are selected because they can change a decision, not because a broad panel feels comprehensive. Results are interpreted with their timing, pretest probability, measurement limitations, recent treatment, and the possibility that an apparently reassuring value was obtained too early or under the wrong conditions.

Progressive course and interpretation#

The clinician creates a symptom and testing timeline, verifies what was actually evaluated, and finds no objective progression, but identifies severe insomnia, deconditioning, panic episodes, and medication related dizziness. Neurologic examination is stable and there are no inflammatory, bleeding, or constitutional warning signs. Regular planned visits replace crisis driven testing. A shared plan targets sleep, graded function, medication simplification, and cognitive behavioral strategies, while a written change threshold states exactly which new findings would reopen diagnostic evaluation.

The trajectory is evidence. Improvement after an intervention may support a mechanism without proving it, while nonresponse should prompt a check of the diagnosis, delivery of the intervention, timing, adherence, and competing pathology. Discordant data should be explained rather than averaged away.

Management reasoning#

• Provide one consistent clinical home. Scheduled visits with a shared summary reduce fragmented emergency testing and allow trajectory to be recognized.
• Treat identified contributors. Address sleep, mood, panic, medication effects, pain coping, autonomic symptoms, and deconditioning according to the positive formulation.
• Set graded functional goals. Small measurable steps in activity, sleep timing, work participation, and social function create progress without demanding symptom elimination first.
• Use diagnostic tests selectively. Every new test should have a named hypothesis, expected interpretation, and management consequence to limit false positives and procedural cascades.
• Protect against diagnostic overshadowing. A written red flag and objective change pathway ensures that future disease is assessed on its evidence rather than dismissed because of the prior diagnosis.

Management remains proportional to severity and uncertainty. It includes explicit monitoring targets, foreseeable adverse effects, and stop or escalation conditions. Exact drug selection, dosing, and procedure details depend on verified individual factors, current local protocols, contraindications, and the responsible treating team; the analytical value here is the decision structure and its guardrails.

Communication and shared decisions#

Validate that symptoms are distressing and do not require visible structural damage to deserve treatment. Summarize positive findings and meaningful negatives without saying it is all in the head. Explain why another broad panel can create false positive results and more procedures, then agree on a limited set of hypotheses, functional goals, and a scheduled review that does not depend on symptom escalation to gain access.

The communication task includes what is known, what remains uncertain, why the next step is recommended, what alternatives exist, and which change should trigger urgent reassessment. Teach-back, qualified interpretation when needed, accessible formats, and a named owner for pending results turn information into a safer plan.

Continuity and safety net#

• Seek urgent assessment for new focal weakness, persistent speech or vision change, fainting with injury, major bleeding, sustained fever, or breathing difficulty.
• Use the scheduled contact route when symptoms flare without red flags so the plan can be adjusted without another undirected emergency workup.
• Report suicidal thoughts, inability to eat or drink, dangerous substance use, or loss of basic self-care immediately.
• Review the shared problem summary at each new setting and correct inaccurate copied diagnoses or tests before further investigation.

Follow-through is verified, not assumed. The record should identify who receives each pending result, the time window for reassessment, the contingency if contact fails, and the clinical or functional outcome that will show whether the plan is working.

Equity and systems analysis#

People with persistent symptoms may experience stigma related to gender, race, body size, disability, trauma, or prior psychiatric diagnoses. Review assumptions explicitly and offer the same red flag assessment used for anyone else. Frequent visits and therapy can be inaccessible, so consolidate care, use telehealth only when usable, provide language access, and choose low cost function based interventions.

Access conditions belong in the causal model. Transportation, medication cost, work schedules, caregiving, health literacy, language, disability access, digital connectivity, and prior experiences of care can alter both the observed presentation and the feasibility of the plan. Addressing those constraints improves diagnostic validity as well as fairness.

Reasoning capabilities demonstrated#

• Validates symptom reality while setting evidence based limits on repetitive testing.
• Builds a positive formulation from function, sleep, mood, medicines, physiology, and behavior.
• Defines objective change thresholds that protect against later diagnostic overshadowing.
• Uses longitudinal continuity to detect both improvement and genuinely new disease.
• Measures treatment through function and participation as well as symptom intensity.

Key takeaways#

• Repeated negative tests are evidence, but they are not a diagnosis and do not make symptoms unreal.
• Planned continuity and hypothesis driven testing can reduce harm while maintaining a route for new objective findings.
• A functional treatment plan should address sleep, medicines, mood, activity, and the person's own goals.